Feladilimab, known as GSK3359609, represents a important step in immunotherapy treatment. This modified monoclonal antibody uniquely targets {CD47|, the "don't eat me" signal, a molecule expressed on various cell https://gsk3359609011173.wikiannouncing.com/user